Sanofi Pasteur has put together a wealth of coding resources
for the 2019-2020 flu season. Coding and billing for vaccinations can be
complicated, so these resources are designed to save your practice time.
Sanofi has scheduled two webinars to assist in flu coding.
One is targeted at coding for patients of any age, and the other is
specifically for pediatric patients. The all ages webinar is scheduled for
August 20 and September 12, 18, and 19. The pediatric webinar is scheduled for
August 21 and September 10. The webinar will cover essential coding and billing
information, Medicaid billing and VFC, Medicare billing, and payment
The second guide, 2019-2020
Proper Codes of Sanofi Pasteur Products, includes product codes, NDCs in
billing format, IDC-10 codes, administration codes, and CVX codes for each
vaccine. It has been updated to include this year’s flu vaccinations.
This post is
the second in a series on increasing adolescent immunizations. For a case study
on how one health system increased their overall adolescent vaccination rates,
see our previous post.
The CPP 2nd Dose Program provides an opportunity to examine your practice’s 2nd dose immunization rates for vaccines that require more than one dose to complete the series, access resources to help implement a strategy in your office to raise those rates, and share successful strategies with other CPP members. Applicable vaccines include meningococcal ACWY, HPV, adult pneumococcal and/or adult hepatitis B (Heplisav-B only).
The tables below show immunization rates for these vaccines for the most recent year available from the CDC:
in CPP’s 2nd Dose Program have already seen successes. Over 77%
of member participants reported that their 2nd dose immunization rates were
lower than they expected when they pulled the initial data from their
EMR. After implementing an intervention in their practice to help improve
these rates, participants saw a rise in their HPV and MCV4 completion rates by an
average of 29% and 41%, respectively!
best practices that were shared by the group include:
CPP understands that changes to vaccine pricing can be a challenge for member practices to navigate. Therefore, CPP has put together several tools to help you manage through the process, from the time you receive the new price notification through 90 days post-implementation.
Sanofi Pasteur and Merck recently announced updated catalog pricing on many of their vaccines. Please note that due to CPP’s contract negotiations with these vendors, CPP members can continue to purchase vaccines at the pre-increase price until the following:
Sanofi Pasteur: 1/1/2019 implementation date
Merck: 2/13/2019 implementation date
Also effective 1/1/2019, Sanofi Pasteur is eliminating the $25 service fee currently assessed on non-influenza vaccine shipments less than $600. The policy change is a direct result of our strong partnership with Sanofi Pasteur and feedback from you. They’ve made this change to better meet your needs.
Come stop by the CPP Buying Group booth (# 425) in the exhibit hall during the conference!
CPP will also be sponsoring the Independent/Solo Small Practice Member Interest Group meeting on Friday, September 23 from 12:30PM-2:30PM. We will be sharing information and resources related to vaccine management with all of the attendees!
We are excited to announce a new partnership between CPP and Pfizer that will provide CPP members an opportunity to save on purchases of Trumenba®, a meningococcal group B vaccine! In order to receive the CPP discount, doses must be purchased directly from Pfizer using your Pfizer account.
For exact details regarding this savings opportunity and to obtain a copy of the opt-in form for this portion of the CPP program, please contact the CPP office at 614-722-2145 or firstname.lastname@example.org.
We wanted to make you aware of several updates regarding Sanofi Pasteur vaccines:
Customer End-of-Year Promotion – CPP Members will receive an additional 3% discount off of Menactra® and Adacel® doses ordered between now and Wednesday, December 16, 2015. Orders must ship by Thursday, December 17, 2015.
Pentacel® Supply – Sanofi Pasteur is experiencing a manufacturing delay with Pentacel® and anticipates it will not be able to meet full demand throughout the first half of 2016. In an effort to manage through this period, they are implementing customer level allocations – about 65%-85% of your monthly demand. To help offset the gap in Pentacel® vaccine supply, Daptacel®, ActHIB®, and IPOL® will be be available at 125% of demand so that you have single-entity vaccines available to cover any pentacel shortage and maintain your immunization schedule.
CPP recommends members consider purchasing the entire allocated amount of Pentacel® for your practice each month in order to maintain your level of allocation throughout the entire period of constrained supply.
Price Increases – Sanofi Pasteur has announced price increases to many of their vaccines.
The new pricing for Adacel®, Diphtheria and Tetanus, Tenivac®, Tubersol®, Imogam® Rabies HT, Typhim Vi® and YF-Vax® will go into effect January 1, 2016.
Due to the supply issue mentioned above, the new pricing for Pentacel®, Daptacel®, IPOL®, and ActHIB® will be delayed and will go into effect July 1, 2016.
If you have any questions, please contact your Sanofi Pasteur representative or the CPP office at 614-722-2145.